AI / data analytics / healthtech / informatics

#AI / data analytics / healthtech / informatics #Informatics #Laboratory data #Public health

Combined group to improve outcomes in diagnostics and lab informatics  

CliniSys has acquired Horizon Lab Systems and combined with Sunquest Information Systems, to create an organisation dedicated to diagnostic and laboratory informatics.  Outlook  CliniSys’ vision is to embrace a new wave of digital diagnostics and laboratories across the continuum of care and community to improve public health.  Horizon… Read More

#News #Trending News

#AI / data analytics / healthtech / informatics #Comment #Drug discovery #SLAS2022

Comment: AI-powered drug discovery 

The Winter issue of the Drug Discovery World Magazine is accompanied by an exclusive DDW & SLAS2022 supplement ahead of SLAS2022 in Boston, US on 5-9 February. As we all look forward to the expertise at the event, DDW’s Megan Thomas outlines the highlights of the first SLAS 2021 AI-Powered Drug Discovery… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#AI / data analytics / healthtech / informatics #Drug discovery

DDW exclusive: 2022 drug discovery challenges and opportunities 

DDW’s Megan Thomas spoke to key decision-makers from the drug discovery industry about their predictions on what 2022 holds for our sector, which can be downloaded and viewed for free from the DDW App for users of Apple or Android devices. “Carefully distinguishing true opportunities from passing fads will… Read More

#News #Trending News

Artificial Intelligence
#AI / data analytics / healthtech / informatics #Collaboration #Drug discovery

BenevolentAI announces collaboration with AstraZeneca 

BenevolentAI, a clinical-stage AI drug discovery company, has expanded its AI-driven drug discovery collaboration with AstraZeneca, doubling the number of disease areas being explored through the partnership.   The expansion  The expansion builds on the collaboration initiated in 2019 and adds systemic lupus erythematosus (SLE) and… Read More

#News

#AI / data analytics / healthtech / informatics #Biotechnology #Database #Drug development #R&D #Research

Bridging the gap between R&D teams in biotechnology   

Ashu Singhal, President & Co-Founder of Benchling, shares newly heightened expectations for the biotechnology industry following the developments of the last 18 months.   The last 18 months have heightened expectations for the biotechnology industry. Scientists came together to develop vaccines at record speeds and set the… Read More

#News

Artificial Intelligence
#AI / data analytics / healthtech / informatics #Biotechnology #Drug discovery #Drug targets

Collaboration to use AI for drug design and retrosyntheis 

The Drug Discovery Unit (DDU) in the School of Life Sciences at The University of Dundee is using Iktos’ generative modelling artificial intelligence (AI) technology in one of its drug discovery programmes.  The collaboration   Iktos will apply its de novo ligand and structure-based generative modelling technologies, its AI-based… Read More

#News

#AI / data analytics / healthtech / informatics #AstraZeneca #Drug targets #Immunology

AstraZeneca uses AI platform to target idiopathic pulmonary fibrosis 

AstraZeneca has added a novel target for idiopathic pulmonary fibrosis (IPF) to its drug development portfolio, discovered using BenevolentAI’s platform. This is reportedly the second novel target from the collaboration that has been identified, validated, and selected for AstraZeneca’s portfolio.   The collaboration  BenevolentAI’s collaboration with AstraZeneca currently focuses… Read More

#News #Trending News

#AI / data analytics / healthtech / informatics #Lab automation

Scitara launches platform to support laboratory digital transformation

The Scitara Scientific Integration Platform (SIP) has been designed as a solution to the lab connectivity challenge that is common in the industry and reportedly allows true data mobility throughout the scientific enterprise.  What is the SIP?  The SIP category is a cloud native infrastructure that allows… Read More

#News

#AI / data analytics / healthtech / informatics #Drug development #Rare disease

Can real-world data transform the rare disease research landscape? 

Cytel and Pulse Infoframe have collaborated to create a solution that marks a new direction in research for rare disease. This partnership will support drug development sponsors seeking to implement real-world evidence solutions where the data generated can be used for a range of purposes, from synthetic controls and comparative effectiveness to… Read More

#News

#AI / data analytics / healthtech / informatics #Drug design

Iktos and Chiesi Group in AI drug design collaboration

Iktos, which specialises in artificial intelligence (AI) for new drug design, is teaming up with Chiesi Group. Under the agreement, Iktos’s de novo generative design software Makya will be used by Chiesi scientists for the design of novel compounds and to accelerate hit-to-lead/lead optimisation. Iktos’ AI technology, based on deep generative models,… Read More

#News

#AI / data analytics / healthtech / informatics #Healthcare #Life sciences

Survey reveals 83% of life science companies fail to track real-time data 

Since South African scientists successfully sequenced the Omicron variant on November 19, the variant – also known as B.1.1.529 – has now been identified internationally. Tracking cases and speeding up booster jabs is critical, but a survey by Solace of 840 IT professionals revealed that only 17% of life… Read More

#News

#AI / data analytics / healthtech / informatics #Clinical trials #Drug discovery

First-in-Human Study of a novel drug discovered using AI platform 

Insilico Medicine, an artificial intelligence (AI)-driven drug discovery company, has announced that the first healthy volunteer has been dosed in a first-in-human microdose trial of ISM001-055.  What is ISM001-055?  ISM001-055 is a potentially first-in-class small molecule inhibitor of a novel biological target discovered by Pharma.AI, Insilico Medicine’s end-to-end AI-powered… Read More

#News

#AI / data analytics / healthtech / informatics #AstraZeneca #Drug development #Funding #Research #Technology

Next wave of innovation: AstraZeneca £1bn R&D centre 

AstraZeneca has unveiled The Discovery Centre (DISC) in Cambridge, UK – a research and development (R&D) facility designed to the world’s highest environmental standards and accommodating over 2,200 research scientists.  The new £1 billion facility will include advanced robotics, high-throughput screening and AI-driven technology. It will support AstraZeneca’s focus… Read More

#News

#AI #AI / data analytics / healthtech / informatics #Chemistry #Drug discovery

Machine learning needs Big Data to revolutionise drug discovery

Machine learning (ML) holds the promise to revolutionise drug discovery. By integrating vast datasets into predictive models, ML will help researchers arrive at the optimal candidate compounds more quickly, disrupting the long cycle times of preclinical discovery research. DEL technology is unmatched in its ability to produce ultra-large datasets. By… Read More

#Editor's Choice #Exclusive Content #Intelligence #News #Opinion #Trends & Analysis

#AI / data analytics / healthtech / informatics #Drug discovery

AI acquisition accelerates outcomes in early drug discovery 

X-Chem has announced the acquisition of Glamorous AI, combining X-Chem’s DNA-encoded library (DEL) data with the AI capabilities of Glamorous AI. This reportedly positions X-Chem as a leading service provider in machine learning-driven drug discovery.  “What AlphaFold did for protein folding, X-Chem and Glamorous AI will do for drug… Read More

#News

#AI / data analytics / healthtech / informatics #Informatics #Technology

New platform integrates scientific data silos 

PerkinElmer has launched the Signals Research Suite, a secure informatics platform deployed on Amazon Web Services which provides scientific data and workflow management for pharmaceutical and industrial customers.   Designed to help drive more informed and accelerated decision-making around drug, compound and formulation candidates, the offering brings together… Read More

#News